Although mIAS is recognized as a distinct clinical entity, clinical trials assessing mIAS have often utilized a variety of descriptive terms to identify this condition, including oral mucositis and stomatitis. The differential diagnosis of mIAS includes recurrent aphthous stomatitis, which may also occur during treatment but is unrelated to mTOR inhibition. The gene discussed is MTOR; the disease is oral mucositis.